"We specialize in the treatment of skin cancer using Mohs surgery, laser surgery, and cosmetic dermatology."

During the past decade, Rochester Dermatologic Surgery conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rochester Dermatologic Surgery" #1 collaborator was "Sanofi" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rochester Dermatologic Surgery" are "Actinic Keratosis" (1 trials), "Basal Cell Carcinoma" (1 trials), "Cutaneous Squamous Cell Carcinoma" (1 trials), "Keratosis" (1 trials) and "Keratosis, Actinic" (1 trials). Many other conditions were trialed in "Rochester Dermatologic Surgery" in a lesser frequency.

Most popular intervention types in "Rochester Dermatologic Surgery" are "Combination Product" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "BF-200 ALA and red light LED lamp" (1 trials), "Cemiplimab" (1 trials), "Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT)" (1 trials) and "Placebo Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rochester Dermatologic Surgery" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Rochester Dermatologic Surgery". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rochester Dermatologic Surgery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rochester Dermatologic Surgery, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".